This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.
Individuals age 15 or older OR parent/guardian of a patient younger than 15 years (if age 15-17, the patient will provide assent and parent/guardian will provide consent), pregnant women will also be allowed to participate
English fluency
Receive genetic counseling specifically for TP53 genetic testing and who consent to undergo TP53 genetic testing OR individuals whose genetic testing indicates a TP53 germline mutation
Individuals who are non-English speaking
Individuals having low suspicion for a TP53 germline mutation during pretest counseling and test negative for a TP53 mutation
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator